Luis Pedro Afonso
Overview
Explore the profile of Luis Pedro Afonso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cotton S, Ferreira D, Relvas-Santos M, Brandao A, Afonso L, Miranda A, et al.
Mol Oncol
. 2024 Nov;
19(3):635-658.
PMID: 39508360
Colorectal cancer (CRC) cells express sialylated Lewis antigens (sLe), crucial for metastasis via E-selectin binding. However, these glycoepitopes lack cancer specificity, and E-selectin-targeted glycoproteins remain largely unknown. Here, we established...
2.
Ortigao R, Afonso L, Pimentel-Nunes P, Dinis-Ribeiro M, Libanio D
GE Port J Gastroenterol
. 2024 Jul;
31(4):236-245.
PMID: 39022301
Introduction/aim: Gastric neuroendocrine tumors (GNETs) frequently have an indolent clinical course, despite their metastatic potential. The aim of the study was to identify prognostic factors associated with overall survival and...
3.
Soares J, Eiras M, Ferreira D, Santos D, Relvas-Santos M, Santos B, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612533
Colorectal cancer (CRC) screening relies primarily on stool analysis to identify occult blood. However, its sensitivity for detecting precancerous lesions is limited, requiring the development of new tools to improve...
4.
Ferreira E, Ferreira D, Relvas-Santos M, Freitas R, Soares J, Azevedo R, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542435
Muscle-invasive bladder cancer (MIBC) remains a pressing health concern due to conventional treatment failure and significant molecular heterogeneity, hampering the development of novel targeted therapeutics. In our quest for novel...
5.
Baia C, Sousa A, Sousa F, Santos P, Varelas A, Afonso L, et al.
J Surg Case Rep
. 2024 Feb;
2024(2):rjae026.
PMID: 38322359
The authors present a case involving a 51-year-old male who was diagnosed with a 4-cm mass in the body of the pancreas, initially suspected to be a ductal adenocarcinoma due...
6.
Pocas J, Marques C, Gomes C, Otake A, Pinto F, Ferreira M, et al.
Proc Natl Acad Sci U S A
. 2023 May;
120(20):e2214853120.
PMID: 37155874
Gastric cancer is a dominating cause of cancer-associated mortality with limited therapeutic options. Here, we show that syndecan-4 (SDC4), a transmembrane proteoglycan, is highly expressed in intestinal subtype gastric tumors...
7.
Pimentel-Nunes P, Ortigao R, Afonso L, Bastos R, Libanio D, Dinis-Ribeiro M
GE Port J Gastroenterol
. 2023 Apr;
30(2):98-106.
PMID: 37008523
Introduction: Gastrointestinal neuroendocrine tumors (GI-NETs) are being more frequently diagnosed and treated by endoscopic resection (ER) techniques. However, comparison studies of the different ER techniques or long-term outcomes are rarely...
8.
Correia A, Ribeiro C, Videira F, Gigliano D, Cunha A, Afonso L, et al.
Ann Hepatobiliary Pancreat Surg
. 2022 Aug;
27(1):102-106.
PMID: 36003000
Hepatocellular carcinoma (HCC) accounts for most of the hepatic neoplasms and can also occur in ectopic liver tissue. We present a case of a 55-year-old male complaining of weight loss....
9.
Carvao J, Libanio D, Rodriguez-Carrasco M, Moura M, Afonso L, Dinis-Ribeiro M
Endoscopy
. 2021 Mar;
54(2):E71-E72.
PMID: 33723838
No abstract available.
10.
Barbosa J, Faria J, Garcez F, Leal S, Afonso L, Nascimento A, et al.
Pharmaceuticals (Basel)
. 2021 Jan;
14(2).
PMID: 33513867
Tramadol and tapentadol, two structurally related synthetic opioid analgesics, are widely prescribed due to the enhanced therapeutic profiles resulting from the synergistic combination between μ-opioid receptor (MOR) activation and monoamine...